UNSPSC 51102858: Hydrocortisone/polymyxin b

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OT250. This VA Drug Class (OT250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL OTIC.

UNSPSC 51102858 Hydrocortisone/polymyxin b is a Commodity code that nominally names a specific topical antibiotic combination, yet recent state and local solicitations tagged under it span pharmaceutical procurement far more broadly — including naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, direct-to-manufacturer prescription programs, and medical and first aid supplies for emergency response. The mismatch between the code's narrow product name and the scope of actual buying suggests either misapplication of the code in tagging or a state-local convention that uses this Commodity code as a catch-all for pharmaceutical and medical-supply procurement. State and local buyers under this code include county health agencies (Seminole County, Florida), state health and human services departments (Texas HHS Commission), cities and their public safety divisions (Tampa Fire Department), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving participating states including Oregon). The issuing bodies reflect a mix of direct procurement for immediate operational needs and strategic platform-building for ongoing multi-vendor pharmaceutical supply.

Recent activity clusters in Florida, Texas, and Minnesota. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's Bid 26-P-00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department, estimated at $700,000.00 with a 5 percent SLBE bid discount; the Minnesota Multistate Cooperative Purchasing Alliance RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers effective July 1, 2026; and the Texas HHS Commission RFI HHS0017013 (posted April 3, 2026, due April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional PBM and GPO channels. Procurement vehicles include traditional sealed bid and RFP processes, multistate cooperative purchasing frameworks, and exploratory RFIs informing future state health program strategy.